Arakis

About:

Arakis Limited focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.

Website: http://www.arakis.com

Top Investors: Novo Holdings, Scottish Equity Partners, 3i Group, Excalibur Fund Managers, Alice Ventures

Description:

Arakis Limited is focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy. The company's research capability specializes in the cytokine and receptor mediated mechanisms of disease. The company identifies, develops, and commercializes product opportunities based upon new clinical uses for known drugs or known drug templates, as well as termed performance enhanced medicines.

Total Funding Amount:

49M GBP

Headquarters Location:

London, England, United Kingdom

Founded Date:

2000-01-01

Founders:

Robin Bannister

Number of Employees:

51-100

Last Funding Date:

2004-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai